Increased chemiluminescence of polymorphonuclear leucocytes from patients with progressive systemic sclerosis. 1986

I B Kovacs, and R H Meyrick Thomas, and A R Mackay, and M H Rustin, and J D Kirby

Chemiluminescence (CL) of whole blood and isolated polymorphonuclear leucocytes (PMN) from patients with systemic sclerosis (SS) and from age and sex matched controls was measured. CL was induced by the addition of particles (zymosan, latex beads), or phorbol myristate acetate (PMA) or chemotactic peptide (FMLP). Whole blood CL (induced by PMA, zymosan or latex particles) was significantly greater in SS patients than in normal controls. Isolated PMN CL (induced by PMA, FMLP or latex particles) was also significantly greater in the SS patients compared with controls. Increased CL or PMN from patients with SS was mainly observed when luminol was used as amplifier (which detects hydrogen peroxide formation). In most cases, lucigenin-amplified CL of PMN from patients with SS (which detects the primary superoxide anion radical formation) did not differ from the controls. Sera from patients with SS significantly increased both spontaneous and induced CL of normal PMN. Enhanced excitability of PMN to phagocytosis-related stimuli may provide a mechanism for the (leucocyte-mediated) endothelial injury in SS.

UI MeSH Term Description Entries
D008163 Luminescent Measurements Techniques used for determining the values of photometric parameters of light resulting from LUMINESCENCE. Bioluminescence Measurements,Bioluminescent Assays,Bioluminescent Measurements,Chemiluminescence Measurements,Chemiluminescent Assays,Chemiluminescent Measurements,Chemoluminescence Measurements,Luminescence Measurements,Luminescent Assays,Luminescent Techniques,Phosphorescence Measurements,Phosphorescent Assays,Phosphorescent Measurements,Assay, Bioluminescent,Assay, Chemiluminescent,Assay, Luminescent,Assay, Phosphorescent,Assays, Bioluminescent,Assays, Chemiluminescent,Assays, Luminescent,Assays, Phosphorescent,Bioluminescence Measurement,Bioluminescent Assay,Bioluminescent Measurement,Chemiluminescence Measurement,Chemiluminescent Assay,Chemiluminescent Measurement,Chemoluminescence Measurement,Luminescence Measurement,Luminescent Assay,Luminescent Measurement,Luminescent Technique,Measurement, Bioluminescence,Measurement, Bioluminescent,Measurement, Chemiluminescence,Measurement, Chemiluminescent,Measurement, Chemoluminescence,Measurement, Luminescence,Measurement, Luminescent,Measurement, Phosphorescence,Measurement, Phosphorescent,Measurements, Bioluminescence,Measurements, Bioluminescent,Measurements, Chemiluminescence,Measurements, Chemiluminescent,Measurements, Chemoluminescence,Measurements, Luminescence,Measurements, Luminescent,Measurements, Phosphorescence,Measurements, Phosphorescent,Phosphorescence Measurement,Phosphorescent Assay,Phosphorescent Measurement,Technique, Luminescent,Techniques, Luminescent
D008165 Luminol 5-Amino-2,3-dihydro-1,4-phthalazinedione. Substance that emits light on oxidation. It is used in chemical determinations.
D008297 Male Males
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D010587 Phagocytosis The engulfing and degradation of microorganisms; other cells that are dead, dying, or pathogenic; and foreign particles by phagocytic cells (PHAGOCYTES). Phagocytoses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012595 Scleroderma, Systemic A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA. Sclerosis, Systemic,Systemic Scleroderma,Systemic Sclerosis

Related Publications

I B Kovacs, and R H Meyrick Thomas, and A R Mackay, and M H Rustin, and J D Kirby
August 1989, British journal of experimental pathology,
I B Kovacs, and R H Meyrick Thomas, and A R Mackay, and M H Rustin, and J D Kirby
December 1985, The Journal of rheumatology,
I B Kovacs, and R H Meyrick Thomas, and A R Mackay, and M H Rustin, and J D Kirby
January 1990, Archives of oral biology,
I B Kovacs, and R H Meyrick Thomas, and A R Mackay, and M H Rustin, and J D Kirby
July 1978, The Journal of laboratory and clinical medicine,
I B Kovacs, and R H Meyrick Thomas, and A R Mackay, and M H Rustin, and J D Kirby
March 1992, The British journal of dermatology,
I B Kovacs, and R H Meyrick Thomas, and A R Mackay, and M H Rustin, and J D Kirby
June 1989, Journal of clinical & laboratory immunology,
I B Kovacs, and R H Meyrick Thomas, and A R Mackay, and M H Rustin, and J D Kirby
March 1985, Photochemistry and photobiology,
I B Kovacs, and R H Meyrick Thomas, and A R Mackay, and M H Rustin, and J D Kirby
September 1984, Journal of general microbiology,
I B Kovacs, and R H Meyrick Thomas, and A R Mackay, and M H Rustin, and J D Kirby
January 2005, Clinical and experimental rheumatology,
I B Kovacs, and R H Meyrick Thomas, and A R Mackay, and M H Rustin, and J D Kirby
July 1984, Experientia,
Copied contents to your clipboard!